Nemera’s commitment to patients and employees remains unwavered amid the COVID-19 pandemic


Nemera’s commitment to patients and employees remains unwavered amid the COVID-19 pandemic

The last few weeks have been truly challenging for all of us with the global spread of COVID-19. With governments and health authorities implementing radical safety measures, schools trying to maintain teaching from a distance and companies venturing into new ways to ensure business continuity – none of us imagined we would have to live through times like these.

At Nemera, we are responding to the COVID-19 pandemic by ensuring continuity of our operations for patients and safety of our employees.

We all know that the most vulnerable populations to COVID 19 are elderly people and those who suffer from chronic diseases such as diabetes and asthma. Therefore, continuing production is not an option but an obligation for us to provide life-saving devices to these patients. Our manufacturing teams are working relentlessly and going the extra mile to maintain production so that patients have access to these critical devices.

Our people are our biggest asset and their safety is critical. With this in mind, we are complying closely with the local health authorities across the Nemera sites and have implemented work from home, telecommunication and other safety measures. We are monitoring and updating our internal policies according to their recommendations. We, Nemera, are strongly connected even in adverse situations.

Last but not the least, we are taking our duty of containing the coronavirus seriously and remain just as committed to our purpose of putting patients first.

About Nemera

Nemera is a world leader in the design, development, and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera offers a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. Nemera’s vision is to be the most patient-centric drug delivery device company. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health

Nemera’s newly branded Insight Innovation Center, with offices in North America and Europe, provides consultative services to support your overall device strategy. Providing user research, Human Factors, User Experience design, and Design for manufacturing, the Insight Innovation Center can help customers navigate their device strategy for both novel and platform solutions. Users are at the center of everything that we do in our effort to always put patients first.

Latest News